Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Roche Holdings Ltd ADR (RHHBY)

Roche Holdings Ltd ADR (RHHBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 FinancialNewsMedia - Thu Jun 20, 7:45AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
KYMR : 30.22 (-2.36%)
RHHBY : 34.4300 (-0.61%)
GILD : 68.40 (-0.35%)
AMGN : 310.77 (-0.08%)
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033 GlobeNewswire - Thu Jun 20, 7:45AM CDT

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
KYMR : 30.22 (-2.36%)
RHHBY : 34.4300 (-0.61%)
GILD : 68.40 (-0.35%)
AMGN : 310.77 (-0.08%)
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments Newswire.ca - Wed Jun 12, 9:22AM CDT

/CNW/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may...

RHHBY : 34.4300 (-0.61%)
ONCY : 0.9900 (-0.52%)
VSTM : 2.93 (-9.69%)
CADL : 6.25 (-0.79%)
FGEN : 0.7430 (-3.52%)
REGN : 1,044.66 (-1.17%)
ONC.TO : 1.37 (+1.48%)
The Fight Against Pancreatic Cancer: Biotech Firms Develop New Solutions for Rising Gen X Cases BayStreet.ca - Wed Jun 12, 9:11AM CDT

USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may be experiencing larger per-capita...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
RHHBY : 34.4300 (-0.61%)
VSTM : 2.93 (-9.69%)
CADL : 6.25 (-0.79%)
FGEN : 0.7430 (-3.52%)
REGN : 1,044.66 (-1.17%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises FinancialNewsMedia - Tue Jun 11, 7:45AM CDT

EQNX::TICKER_START (NASDAQ:TLSA),(NYSE:LLY),(OTCQX:RHHBY),(NASDAQ:BIIB),(NASDAQ:TGTX) EQNX::TICKER_END

TLSA : 0.8590 (-3.00%)
LLY : 906.71 (-0.84%)
RHHBY : 34.4300 (-0.61%)
BIIB : 228.82 (-1.27%)
TGTX : 18.31 (+0.88%)
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises GlobeNewswire - Tue Jun 11, 7:45AM CDT

TLSA : 0.8590 (-3.00%)
LLY : 906.71 (-0.84%)
RHHBY : 34.4300 (-0.61%)
BIIB : 228.82 (-1.27%)
TGTX : 18.31 (+0.88%)
2 Cathie Wood Biotech Stocks That Could Be Worth the Risk Motley Fool - Wed May 29, 5:00AM CDT

You don't need to buy her picks, but it's worth understanding them.

RHHBY : 34.4300 (-0.61%)
ARKK : 44.82 (+0.83%)
ARKG : 22.89 (-1.46%)
DNA : 0.3465 (+7.21%)
RXRX : 7.16 (-4.02%)
If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today Motley Fool - Sun May 26, 7:31AM CDT

What would a $100 investment in Viking Therapeutics back in 2022 be worth today? Prepare to be surprised.

GS : 465.61 (+0.42%)
RHHBY : 34.4300 (-0.61%)
VKTX : 51.54 (-6.83%)
Advancements in Cancer Therapeutics: What to Expect from the Upcoming 2024 Oncology Conference BayStreet.ca - Fri May 24, 10:49AM CDT

USA News Group News Commentary – As the 2024 American Society of Clinical Oncology (ASCO) annual meeting approaches, excitement builds over the latest in cancer treatment advancements, particularly in...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
MRK : 127.72 (-0.14%)
RHHBY : 34.4300 (-0.61%)
AMGN : 310.77 (-0.08%)
BNTX : 78.76 (-0.09%)
Pancreatic Cancer Battle Intensifies with Biotech Sector's Advanced Treatments BayStreet.ca - Fri May 17, 10:48AM CDT

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage pancreatic cancer with 97% accuracy. This breakthrough...

ONCY : 0.9900 (-0.52%)
ONC.TO : 1.37 (+1.48%)
RHHBY : 34.4300 (-0.61%)
MRUS : 53.09 (-2.50%)
MGNX : 4.10 (-4.65%)
IMRX : 1.0900 (-6.84%)

Barchart Exclusives

Is This Copper Mining Stock a Buy for Its Fat Dividend? Barchart - Tue Jul 2, 6:30PM CDT
Southern Copper has a higher dividend yield compared to other copper mining companies. However, its valuations are also on the higher side, making a closer examination of the risk-reward necessary for prospective investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot